Bispecific Antibodies
Akeso’s Cadonilimab Achieves Significant Overall Survival in Severe Gastric Cancer Patients
Anika Sharma
Akeso’s bispecific antibody has demonstrated a significant improvement in overall survival for first-line patients with severe gastric cancer or gastroesophageal ...
Roche abandons oral drug for eye disease after phase 2 failure, shifts focus from solid tumor bispecifics
Anika Sharma
Roche’s ambitious quest to develop an oral treatment for diabetic retinopathy has faced a setback, as the company decided to ...
Abpro to go public via SPAC merger with Atlantic Coastal, raising funds for its HER2xCD3 bispecific and COVID-19 program
Anika Sharma
Abpro is making a return to the public market after a five-year hiatus, this time teaming up with Atlantic Coastal ...
Bispecific Antibodies in Multiple Myeloma: A Combination Leads to Durable Responses
SG Tylor
Bispecific antibodies in multiple myeloma are a new class of drugs that can target two different antigens at the same ...
